Merck
CN
Search Within

314-13-6

应用筛选条件
关键词:'314-13-6'
显示 1-6 共 6 条结果 关于 "314-13-6" 范围 论文
Edward L C Pritchett et al.
American heart journal, 151(5), 1043-1049 (2006-04-29)
Azimilide dihydrochloride (azimilide) is an investigational antiarrhythmic drug that has been tested in patients with a variety of arrhythmias. In patients with atrial fibrillation, it has shown excellent efficacy in some previous trials and minimal efficacy in others. Patients who
Maren Carstensen et al.
Diabetes, 59(5), 1222-1227 (2010-02-27)
Although interleukin-1 receptor antagonist (IL-1Ra) treatment is associated with improved beta-cell function and glycemic control in patients with type 2 diabetes, its role in the development of type 2 diabetes remains unclear. We used repeated measurements to characterize IL-1Ra trajectories
L M Kamendulis et al.
The Journal of pharmacology and experimental therapeutics, 279(2), 713-717 (1996-11-01)
Concomitant i.v. use of cocaine and heroin ("speedballing") is prevalent among drug-abusing populations. Heroin is rapidly metabolized by sequential deacetylation of two separate ester bonds to yield 6-monoacetylmorphine and morphine. Hydrolysis of heroin to 6-monoacetylmorphine is catalyzed by pseudocholinesterase. The
Rasha Mosa et al.
American journal of physiology. Regulatory, integrative and comparative physiology, 314(1), R71-R83 (2017-09-15)
Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice. Am J Physiol Regul Integr Comp Physiol 314: R71-R83, 2018. First published September 13, 2017; doi: 10.1152/ajpregu.00157.2017 .-Ghrelin secretion has been associated
Jörg D Leuppi et al.
JAMA, 309(21), 2223-2231 (2013-05-23)
International guidelines advocate a 7- to 14-day course of systemic glucocorticoid therapy in acute exacerbations of chronic obstructive pulmonary disease (COPD). However, the optimal dose and duration are unknown. To investigate whether a short-term (5 days) systemic glucocorticoid treatment in
Francesco Bisognin et al.
PloS one, 13(8), e0201934-e0201934 (2018-08-14)
The new Xpert MTB/RIF Ultra assay (Ultra, Cepheid, Sunnyvale, USA) is a cartridge-based automated diagnostic test that can simultaneously identify Mycobacterium tuberculosis complex (MTB) and resistance to Rifampicin (RIF). With respect to the previous version Xpert MTB/RIF assay (Xpert), IS6110/IS1081
1/1